Immune monitoring design within the developmental pipeline for an immunotherapeutic or preventive vaccine


Autoria(s): Janetzki, S.; Romero, P.; Roederer, M.; Bolton, D.L.; Jandus, C.; Morrow J. (ed.); Sheikh N. (ed.); Schmidt C. (ed.); Davies H. (ed.)
Data(s)

01/06/2012

Resumo

Immunotherapy is defined as the treatment of disease by inducing, enhancing, or suppressing an immune response, whereas preventive vaccination is intended to prevent the development of diseases in healthy subjects. Most successful prophylactic vaccines rely on the induction of high titers of neutralizing antibodies. It is generally thought that therapeutic vaccination requires induction of robust T-cell mediated immunity. The diverse array of potential or already in use immunotherapeutic and preventive agents all share the commonality of stimulating the immune system. Hence, measuring those vaccination-induced immune responses gives the earliest indication of vaccine take and its immune modulating effects.

Identificador

https://serval.unil.ch/notice/serval:BIB_2D27A2A676BC

isbn:978-1-118-34533-7

Idioma(s)

eng

Publicador

Oxford: Wiley-Blackwell

Fonte

Vaccinology: principles and practice28419-440

Tipo

info:eu-repo/semantics/bookPart

incollection